Literature DB >> 19590964

Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Jayaraj Ravindran1, Sahdeo Prasad, Bharat B Aggarwal.   

Abstract

Cancer is a hyperproliferative disorder that is usually treated by chemotherapeutic agents that are toxic not only to tumor cells but also to normal cells, so these agents produce major side effects. In addition, these agents are highly expensive and thus not affordable for most. Moreover, such agents cannot be used for cancer prevention. Traditional medicines are generally free of the deleterious side effects and usually inexpensive. Curcumin, a component of turmeric (Curcuma longa), is one such agent that is safe, affordable, and efficacious. How curcumin kills tumor cells is the focus of this review. We show that curcumin modulates growth of tumor cells through regulation of multiple cell signaling pathways including cell proliferation pathway (cyclin D1, c-myc), cell survival pathway (Bcl-2, Bcl-xL, cFLIP, XIAP, c-IAP1), caspase activation pathway (caspase-8, 3, 9), tumor suppressor pathway (p53, p21) death receptor pathway (DR4, DR5), mitochondrial pathways, and protein kinase pathway (JNK, Akt, and AMPK). How curcumin selectively kills tumor cells, and not normal cells, is also described in detail.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590964      PMCID: PMC2758121          DOI: 10.1208/s12248-009-9128-x

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  256 in total

1.  Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3.

Authors:  Chin-Cheng Su; Jaung-Geng Lin; Te-Mao Li; Jing-Gung Chung; Jai-Sing Yang; Siu-Wan Ip; Wen-Chuan Lin; Guang-Wei Chen
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

2.  Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.

Authors:  Shahar Lev-Ari; Alex Starr; Akiva Vexler; Vicki Karaush; Vered Loew; Joel Greif; Eyal Fenig; Dan Aderka; Rami Ben-Yosef
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

3.  Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression.

Authors:  G Song; Y B Mao; Q F Cai; L M Yao; G L Ouyang; S D Bao
Journal:  Braz J Med Biol Res       Date:  2005-11-09       Impact factor: 2.590

Review 4.  Redox regulation of transcriptional activators.

Authors:  Y Sun; L W Oberley
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

5.  Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants.

Authors:  Mehrdad Khajavi; Ken Inoue; Wojciech Wiszniewski; Tomoko Ohyama; G Jackson Snipes; James R Lupski
Journal:  Am J Hum Genet       Date:  2005-09-30       Impact factor: 11.025

6.  Induction of HSP70 gene expression by modulation of Ca(+2) ion and cellular p53 protein by curcumin in colorectal carcinoma cells.

Authors:  Y C Chen; T C Kuo; S Y Lin-Shiau; J K Lin
Journal:  Mol Carcinog       Date:  1996-12       Impact factor: 4.784

7.  Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and -independent apoptosis in L929 cells.

Authors:  Faisal Thayyullathil; Shahanas Chathoth; Abdulkader Hago; Mahendra Patel; Sehamuddin Galadari
Journal:  Free Radic Biol Med       Date:  2008-08-16       Impact factor: 7.376

8.  Cytotoxic effects of curcumin on osteosarcoma cell lines.

Authors:  Denise K Walters; Roman Muff; Bettina Langsam; Walter Born; Bruno Fuchs
Journal:  Invest New Drugs       Date:  2007-12-11       Impact factor: 3.850

9.  Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells.

Authors:  Jun Cao; Yong Liu; Li Jia; Hui-Min Zhou; Ying Kong; Guang Yang; Li-Ping Jiang; Qiu-Juan Li; Lai-Fu Zhong
Journal:  Free Radic Biol Med       Date:  2007-06-13       Impact factor: 7.376

10.  Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer.

Authors:  Tanja Andrzejewski; Dorrah Deeb; Xiaohua Gao; Andrew Danyluk; Ali S Arbab; Scott A Dulchavsky; Subhash C Gautam
Journal:  Oncol Res       Date:  2008       Impact factor: 5.574

View more
  194 in total

1.  Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells.

Authors:  Lei Shi; Xifeng Fei; Zhimin Wang
Journal:  Tumour Biol       Date:  2015-04-16

Review 2.  Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Ganesan Padmavathi; Javadi Monisha; Nand Kishor Roy; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2016-10-21       Impact factor: 8.739

3.  Induction of apoptosis in prostate cancer cells by the novel ceramidase inhibitor ceranib-2.

Authors:  Gokhan Kus; Selda Kabadere; Ruhi Uyar; Hatice Mehtap Kutlu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-07-14       Impact factor: 2.416

4.  Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles.

Authors:  Aysegul Altunbas; Seung J Lee; Sigrid A Rajasekaran; Joel P Schneider; Darrin J Pochan
Journal:  Biomaterials       Date:  2011-05-23       Impact factor: 12.479

Review 5.  Natural compounds as anticancer agents: Experimental evidence.

Authors:  Jiao Wang; Yang-Fu Jiang
Journal:  World J Exp Med       Date:  2012-06-20

6.  Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.

Authors:  Ji Wang; Chunying Wang; Gaofeng Bu
Journal:  Exp Ther Med       Date:  2018-01-29       Impact factor: 2.447

7.  In vitro study of the cytotoxicity of thymoquinone/curcumin fluorescent liposomes.

Authors:  Heba Mohamed Fahmy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-03       Impact factor: 3.000

Review 8.  Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression.

Authors:  Zhiwei Wang; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Stem Cell Res Ther       Date:  2010-03       Impact factor: 3.828

9.  Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: towards targeting of cancer stem cells with phytochemicals.

Authors:  Dunne Fong; Arthur Yeh; Rotem Naftalovich; Theresa Hyejeong Choi; Marion M Chan
Journal:  Cancer Lett       Date:  2010-01-20       Impact factor: 8.679

10.  Curcumin suppresses proliferation and invasion in non-small cell lung cancer by modulation of MTA1-mediated Wnt/β-catenin pathway.

Authors:  Yimin Lu; Changjiang Wei; Zhaoqing Xi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-06-18       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.